True histiocytic lymphoma following therapy for lymphoblastic neoplasms. [electronic resource]
Producer: 19960731Description: 5207-12 p. digitalISSN:- 0006-4971
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Asparaginase -- administration & dosage
- Bone Neoplasms -- chemically induced
- Child
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Fatal Outcome
- Humans
- Ifosfamide -- administration & dosage
- Lymphoma, Large B-Cell, Diffuse -- chemically induced
- Male
- Mediastinal Neoplasms -- drug therapy
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Methylprednisolone -- administration & dosage
- Neoplasms, Second Primary -- chemically induced
- Neoplastic Stem Cells -- pathology
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisolone -- administration & dosage
- Prednisone -- administration & dosage
- Remission Induction
- Scapula -- pathology
- Spinal Neoplasms -- chemically induced
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.